Skip to main content
Log in

Thyrotoxicosis factitia complicating Graves’ disease

  • Case Report
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Summary

A patient with Graves’ disease remained clinically and biochemically hyperthyroid after intravenous therapeutic131I, although thyroidal uptake fell to normal. Previously she had taken antithyroid drugs irregularly and vomited twice after oral131I. She was treated with carbimazole and thyroxine 0.2 mg daily because of severe exophthalmos. However, she maintained her hypermetabolic state by surreptitiously taking thyroxine in excess of the prescribed dose. When drug treatment was stopped under supervision she rapidly became euthyroid. By tracing prescriptions supplied to the patient it was shown that she had obtained amounts of thyroxine grossly in excess of her requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bricaire, H., Moreau, L., Joly, J., Saltiel, H., Milgrom, E. 1967. Les thyreotoxicoses factices. Revue Francaise. L’Endocrinologie Clinique, Nutrition et Metabolisme 8, 99.

    CAS  Google Scholar 

  • Chamovitz, D. L., Sleisenger, M. H., Freedberg, A. S. 1951. Thyrotoxicosis factitia: measurement of the thyroid gland131I uptake and serum protein-bound131I. Amer. J. Med. 11, 255.

    Article  PubMed  CAS  Google Scholar 

  • Gorman, C. A., Wahner, H. W., Tauxe, W. N. 1970. Metabolic malingerers; patients who deliberately induce or perpetuate a hypermetabolic or hypometabolic state. Amer. J. Med. 48, 708.

    Article  PubMed  CAS  Google Scholar 

  • Hamilton, C. R., Maloof, F. 1973. Unusual types of hyperthyroidism. Medicine 52, 195.

    Article  Google Scholar 

  • Harvey, R. F. 1973. Thyroxine “addicts”. Brit. Med. J. ii, 35.

    Google Scholar 

  • Hooper, M. J., Ratcliffe, J. G., Ratcliffe, W. A., Spencer, C. A., McLarty, D. G., Alexander, W. D. 1975. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis. J. Clin. Endocr. Metab. 40, 807.

    Article  PubMed  CAS  Google Scholar 

  • Koutras, D. A., Alexander, W. D., Harden, R. McG., Wayne, E. 1964. Effect of small iodine supplements on thyroid function in normal individuals. J. Clin. Endocr. Metab. 24, 857.

    PubMed  CAS  Google Scholar 

  • Rose, E., Sanders, T. P., Webb, W. L., Hines, R. C. 1969. Occult factitial thyrotoxicosis: thyroxine kinetics and psychological evaluation in three cases. Ann. Int. Med. 71, 309.

    PubMed  CAS  Google Scholar 

  • Skanse, B. T., Riggs, D. S. 1948. Thyrotoxicosis factitia (alimentary thyrotoxicosis). J. Clin. Endocr. 8, 532.

    CAS  PubMed  Google Scholar 

  • Wayne, E. J., Koutras, D. A., Alexander, W. D. 1964. Clinical aspects of iodine metabolism. pp. 229–236. Blackwell, Oxford.

    Google Scholar 

  • Werner, S. C. 1969. Classification of the eye changes in Graves’ disease. J. Clin. Endocr. Metab. 29, 982.

    PubMed  CAS  Google Scholar 

  • Zellmann, H. E. 1972. Hyperthyroidism. Med. clinics North Amer. 56, 717.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferriss, J.B., Hooper, M.J. Thyrotoxicosis factitia complicating Graves’ disease. IJMS 145, 260–262 (1976). https://doi.org/10.1007/BF02938957

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938957

Keywords

Navigation